Search Results
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
Search for other papers by Shenglong Le in
Google Scholar
PubMed
Search for other papers by Leiting Xu in
Google Scholar
PubMed
The Key Laboratory of Systems Biomedicine, Ministry of Education, and Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China
Search for other papers by Moritz Schumann in
Google Scholar
PubMed
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
Search for other papers by Na Wu in
Google Scholar
PubMed
Search for other papers by Timo Törmäkangas in
Google Scholar
PubMed
Search for other papers by Markku Alén in
Google Scholar
PubMed
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
The Key Laboratory of Systems Biomedicine, Ministry of Education, and Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China
Search for other papers by Sulin Cheng in
Google Scholar
PubMed
Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland
Department of Epidemiology and Biostatistics, Centre for Environment and Health, School of Public Health, Imperial College London, London, UK
Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
Search for other papers by Petri Wiklund in
Google Scholar
PubMed
Fischer Scientific Inc.) and fasting serum insulin was determined by immunofluorescence using the IMMULITE Analyzer (Diagnostic Products Corporation, Los Angeles, USA). Insulin-like growth factor 1 (IGF-1) was assessed using time
Search for other papers by Julie M Silverstein in
Google Scholar
PubMed
associated with acromegaly are a consequence of the chronic overproduction of growth hormone (GH) and insulin-like growth factor 1 (IGF1) (1, 8) . Systemic complications commonly associated with the chronic hypersecretion of GH and IGF1 include visceromegaly
Search for other papers by T L C Wolters in
Google Scholar
PubMed
Division of Vascular Medicine, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by C D C C van der Heijden in
Google Scholar
PubMed
Search for other papers by N van Leeuwen in
Google Scholar
PubMed
Search for other papers by B T P Hijmans-Kersten in
Google Scholar
PubMed
Search for other papers by M G Netea in
Google Scholar
PubMed
Search for other papers by J W A Smit in
Google Scholar
PubMed
Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, UK
Search for other papers by D H J Thijssen in
Google Scholar
PubMed
Search for other papers by A R M M Hermus in
Google Scholar
PubMed
Search for other papers by N P Riksen in
Google Scholar
PubMed
Search for other papers by R T Netea-Maier in
Google Scholar
PubMed
Introduction Acromegaly is caused by overproduction of growth hormone (GH), in most cases by a pituitary adenoma. GH in turn induces production of insulin-like growth factor 1 (IGF1) ( 1 ). Both GH and IGF1 have numerous metabolic and trophic
Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed
Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed
Search for other papers by Monica R Gadelha in
Google Scholar
PubMed
normalising insulin-like growth factor 1 (IGF1) levels that are inadequately controlled by octreotide or lanreotide ( 2 ). Long-term outcomes from clinical studies have demonstrated effective and consistent biochemical control with pasireotide for up to 304
Search for other papers by Xu-Ting Song in
Google Scholar
PubMed
Search for other papers by Jia-Nan Zhang in
Google Scholar
PubMed
Search for other papers by Duo-Wei Zhao in
Google Scholar
PubMed
Search for other papers by Yu-Fei Zhai in
Google Scholar
PubMed
Search for other papers by Qi Lu in
Google Scholar
PubMed
Search for other papers by Mei-Yu Qi in
Google Scholar
PubMed
Search for other papers by Ming-Hai Lu in
Google Scholar
PubMed
Search for other papers by Shou-Long Deng in
Google Scholar
PubMed
Search for other papers by Hong-Bing Han in
Google Scholar
PubMed
Search for other papers by Xiu-Qin Yang in
Google Scholar
PubMed
Search for other papers by Yu-Chang Yao in
Google Scholar
PubMed
Introduction Insulin-like growth factor 1 (IGF1), also known as somatomedin C, has remarkable diversity in terms of biological effects. It is widely recognized that IGF1 is essential for the regulation of normal growth ( 1 ), development ( 2
Search for other papers by Rossella Cannarella in
Google Scholar
PubMed
Search for other papers by Andrea Crafa in
Google Scholar
PubMed
Search for other papers by Sandro La Vignera in
Google Scholar
PubMed
Search for other papers by Rosita A Condorelli in
Google Scholar
PubMed
Search for other papers by Aldo E Calogero in
Google Scholar
PubMed
Introduction The acromegaly levels of insulin-like growth factor 1 (IGF1) that occur in healthy children in pubertal age have led to the speculation that this hormone may stimulate the function of the hypothalamus–pituitary–testicular (HPT
Department of Endocrinology, Department of Molecular Medicine and Surgery, Metabolism and Diabetology, Karolinska University Hospital, 171 76 Stockholm, Sweden
Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Search for other papers by Erik Wahlström in
Google Scholar
PubMed
Search for other papers by Petra Tollet-Egnell in
Google Scholar
PubMed
Search for other papers by Gunnar Norstedt in
Google Scholar
PubMed
receptor and indirectly through production in the liver or the periphery of insulin-like growth factor 1 (IGF1). IGF1 circulates bound to a number of binding proteins, of which six high-affinity proteins have been identified and fully characterised. IGF
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Tao Tong in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Zheng Li in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
Introduction Growth hormone-secreting pituitary adenoma (GHPA) is due to the overproduction of growth hormone (GH) by pituitary adenomas, which stimulates the liver to produce insulin-like growth factor 1 (IGF-1), and the long
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Mette Marie Baunsgaard in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Anne Sophie Lind Helligsoe in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Louise Tram Henriksen in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Torben Stamm Mikkelsen in
Google Scholar
PubMed
Search for other papers by Michael Callesen in
Google Scholar
PubMed
Search for other papers by Britta Weber in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Henrik Hasle in
Google Scholar
PubMed
Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark
Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
Search for other papers by Niels Birkebæk in
Google Scholar
PubMed
, GHD can be monitored by linear growth. However, assessment of linear growth is of no use when final height has been reached. Furthermore, insulin-like growth factor 1 (IGF-1) has been questioned as a reliable biochemical proxy marker of GHD in CR
Search for other papers by Elvira C Arellanes-Licea in
Google Scholar
PubMed
Search for other papers by José Ávila-Mendoza in
Google Scholar
PubMed
Search for other papers by Elizabeth C Ramírez-Martínez in
Google Scholar
PubMed
Search for other papers by Eugenia Ramos in
Google Scholar
PubMed
Search for other papers by Nancy Uribe-González in
Google Scholar
PubMed
Search for other papers by Carlos Arámburo in
Google Scholar
PubMed
Search for other papers by Teresa Morales in
Google Scholar
PubMed
Search for other papers by Maricela Luna in
Google Scholar
PubMed
Lactation embodies a natural model of morphological, neurochemical, and functional brain plasticity. In this reproductive stage, the hippocampus of the female is less sensitive to excitotoxins in contrast to nulliparity. Growth hormone (GH) and insulin-like growth factor 1 (IGF1) are known to be neuroprotective in several experimental models of brain lesion. Here, activation of the GH–IGF1 pituitary–brain axis following kainic acid (7.5 mg/kg i.p. KA) lesion was studied in lactating and nulliparous rats. Serum concentrations of GH and IGF1 were uncoupled in lactation. Compared to virgin rats, the basal concentration of GH increased up to 40% but IGF1 decreased 58% in dams, and only GH increased further after KA treatment. In the hippocampus, basal expression of GH mRNA was higher (2.8-fold) in lactating rats than in virgin rats. GH mRNA expression in lactating rats increased further after KA administration in the hippocampus and in the hypothalamus, in parallel to GH protein concentration in the hippocampus of KA-treated lactating rats (43% vs lactating control), as detected by Western blot and immunofluorescence. Except for the significantly lower mRNA concentration in the liver of lactating rats, IGF1 expression was not altered by the reproductive condition or by KA treatment in the hippocampus and hypothalamus. Present results indicate upregulation of GH expression in the hippocampus after an excitotoxic lesion, suggesting paracrine/autocrine actions of GH as a factor underlying neuroprotection in the brain of the lactating dam. Since no induction of IGF1 was detected, present data suggest a direct action of GH.